Day: October 23, 2013

FDA Issues Positive Review for Gilead's Hep C Drug

By Matthew Perrone, AP Health WriterAssociated Press -The Food and Drug Administration issued a positive review Wednesday for a highly anticipated hepatitis C drug from Gilead Sciences, saying the pill cures more patients in less time than currently available treatments.The agency posted its review of Gilead’s sofosbuvir online ahead of a meeting Friday where government experts […]

Infusing Love: The Gasp Factor

We are doing it.We are signing our son with severe hemophilia up for basketball. So why do I feel so weird about it? We have full support from our HTC for him to play and for letting him be overall active.We are a huge sports family; we especially love basketball. Our older girls have played […]

Patient-Focused Drug Development Initiative Update

Dear Member Organizations,As you know, the FDA has recently embarked on a new Patient-Focused Drug Development Initiative, which will include convening 20 disease-specific public meetings to hear directly from patients about their perceptions of risk and benefit when it comes to new and existing treatments. FDA selected bleeding disorders as one of the disease areas […]